We work with world-renowned pharmaceutical organizations such as Biomarin, Recordati Rare diseases, PTC Therapeutics, etc. They help us provide the patients the quality medicines and deliver hard-to-access drugs to needy patients to improve their quality of life.
Ikris Pharma helps in accessing Recordati Rare Disease medicines for patients in India, Nepal, Pakistan & Sri Lanka through strategic alliances and exclusive distribution agreement. Patients from above mentioned countries can directly contact Ikris for Orphan Europe products.
Ikris Pharma Network is authorized by PTC Therapeutics to provide access to their medicines to Indian patients through Named-Patient Import.
Ikris Pharma Network is authorized by Servier to provide access to their medicines to Indian patients through Named-Patient Import.
Founded in 1997, BioMarin is a global biotechnology company dedicated to transforming lives through genetic discovery. The company develops and commercializes targeted therapies that address the root cause of genetic conditions. Ikris Pharma Network is authorized by BioMarin to provide access to the company’s medicines to Indian patients through Named-Patient Import. For more information, click here to visit BioMarin's official website.
Ikris Pharma Network is authorized by Sarepta Therapeutics to provide access to their medicines to Indian patients through Named-Patient Import.
Ikris Pharma Network is authorized by Alexion Pharmaceuticals to provide access to Asfotase Alfa to Indian patients through Named-Patient Import basis.
Join us for innovative collaboration, cutting-edge research, and global healthcare impact. Together, we’ll advance medical science and improve lives.